Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G(2)/M arrest induced by topoisomerase II inhibitors

CD26/dipeptidyl peptidase IV (DPPIV) is a surface antigen with multiple functions, including a role in T-cell activation and the development of certain human cancers. We previously demonstrated that CD26/DPPIV enhanced sensitivity of Jurkat cells to doxorubicin. We now show that expression of CD26/D...

Descripción completa

Detalles Bibliográficos
Autores principales: Aytac, U, Sato, K, Yamochi, T, Ohnuma, K, Mills, G B, Morimoto, C, Dang, N H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747550/
https://www.ncbi.nlm.nih.gov/pubmed/12569391
http://dx.doi.org/10.1038/sj.bjc.6600791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747550/
https://www.ncbi.nlm.nih.gov/pubmed/12569391
http://dx.doi.org/10.1038/sj.bjc.6600791

Ejemplares similares